SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

REGOLI, Domenico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.189
EU - Europa 2.030
AS - Asia 1.509
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 3
OC - Oceania 1
Totale 11.735
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.153
CN - Cina 787
UA - Ucraina 547
DE - Germania 456
SG - Singapore 364
IT - Italia 342
TR - Turchia 337
GB - Regno Unito 278
FI - Finlandia 154
SE - Svezia 114
BE - Belgio 39
CA - Canada 36
FR - Francia 31
RU - Federazione Russa 30
LT - Lituania 14
IN - India 7
CZ - Repubblica Ceca 6
IR - Iran 6
HR - Croazia 3
NL - Olanda 3
AR - Argentina 2
BG - Bulgaria 2
EU - Europa 2
GR - Grecia 2
JP - Giappone 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AT - Austria 1
AU - Australia 1
CL - Cile 1
DK - Danimarca 1
EE - Estonia 1
ES - Italia 1
IE - Irlanda 1
IL - Israele 1
IQ - Iraq 1
KR - Corea 1
MM - Myanmar 1
NO - Norvegia 1
NP - Nepal 1
PL - Polonia 1
RO - Romania 1
Totale 11.735
Salva come PNG Salva come JPEG
Città #
Fairfield 1.109
Woodbridge 1.076
Houston 652
Jacksonville 612
Ann Arbor 559
Chandler 526
Ashburn 524
Seattle 401
Wilmington 392
Cambridge 352
Singapore 293
Santa Clara 236
Izmir 193
Nanjing 178
Beijing 169
Milan 125
Princeton 118
San Diego 109
Boardman 101
New York 79
Shanghai 72
Dearborn 56
Nanchang 56
Shenyang 51
Falls Church 44
Helsinki 39
Munich 39
Brussels 38
Los Angeles 37
Bremen 34
Hebei 32
Auburn Hills 29
Jiaxing 29
Changsha 28
Ferrara 28
Mountain View 27
San Mateo 27
Jinan 26
Tianjin 23
Mcallen 22
Norwalk 22
Philadelphia 20
Redwood City 20
Addison 19
London 19
Kunming 17
Montréal 17
Zhengzhou 17
Indiana 12
Ningbo 12
Tappahannock 12
Toronto 12
Des Moines 10
Augusta 7
Düsseldorf 7
Guangzhou 7
Verona 7
Florence 6
Frankfurt am Main 6
Hounslow 6
Lanzhou 6
Leawood 6
Orange 6
Ottawa 6
Redmond 6
Washington 6
Bologna 5
Ardabil 4
Brno 4
Changchun 4
Hangzhou 4
Monmouth Junction 4
Prescot 4
Taizhou 4
Chiswick 3
Edinburgh 3
Falkenstein 3
Ferrara di Monte Baldo 3
Fuzhou 3
Hefei 3
Zagreb 3
Bolzano 2
Bondeno 2
Brescia 2
Busto Arsizio 2
Chongqing 2
Montechiarugolo 2
New Bedfont 2
Olomouc 2
Portici 2
San Francisco 2
Seregno 2
Sofia 2
Southwark 2
Turin 2
Venice 2
Wandsworth 2
Acton 1
Asciano 1
Athens 1
Totale 8.921
Salva come PNG Salva come JPEG
Nome #
AGONISTI PIENI E PARZIALI ED ANTAGONISTI DEL RECETTORE PER NOCICETTINA/ORFANINA FQ AD ELEVATA POTENZA” 209
Characterization of FR 172357, a new non-peptide bradykinin B2 receptor antagonist, in human, pig and rabbit preparations 169
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 166
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide. 151
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 149
Kinin B-1 and B-2 receptors in pig vessels: characterization of two monoreceptor systems 148
A new selective antagonist of the nociceptin receptor 146
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 145
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 144
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 141
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 141
Pharmacological characterization of nociceptin receptor: an in vitro study 136
A new ligand for the urotensin II receptor 135
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 133
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist 132
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 132
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 129
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 128
Effects of vasoactive agents in healthy and diseased human saphenous veins 128
Ala scan analogues of HOE 140. Synthesis and biological activities 127
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 125
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 122
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 122
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 122
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 121
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: In vitro and in vivo studies 120
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 119
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24. 119
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists. 118
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 117
[Nphe(1)]nociceptin-(1-13)NH2 selectively antagonizes nociceptin effects in the rabbit isolated ileum 116
Structure-activity study at positions 3 and 4 of human neuropeptide S. 116
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist 115
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 114
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor. 112
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 112
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 111
null 111
Studies on the antinociceptive effect of [Nphe(1)]nociceptin(1-13)NH2 in mice 110
B1 and B2 kinin receptors in various species 110
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 110
Effects of intrathecal nocistatin on the flexor reflex and its interaction with orphanin FQ nociceptin 109
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors 109
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 109
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 108
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 108
Bradykinin receptors and receptor ligands (with special emphasis on vascular receptors) 107
Pharmacological characterisation of novel kinin B2 receptor ligands 107
The nociceptin/orphanin FQ receptor antagonist, [Nphe(1)]NC(1-13)NH2, potentiates morphine analgesia 107
Characterization of endothelin receptors in the human umbilical artery and vein 106
Pharmacology of the Kallikrein-Kinin system 106
Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists. 106
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 106
UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor 105
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 105
Urotensin II-induced hypotensive responses in Wistar-Kyoto (Wky) and spontaneously hypertensive (Shr) rats 104
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl] methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vitro studies 104
The mouse vas deferens: A pharmacological preparation sensitive to nociceptin 103
Changes in hippocampal and cortical B1 bradykinin receptor biological activity in two experimental models of epilepsy 102
Structure-activity relationship study on human urotensin II 101
Autoradiographic analysis of rat brain kinin B-1 and B-2 receptors: Normal distribution and alterations induced by epilepsy 101
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with C alpha,alpha-dialkylated amino acids 101
Nociceptin receptor binding in mouse forebrain membranes: Thermodynamic characteristics and structure activity relationships 100
Receptors for kinins in the human isolated umbilical vein. 100
null 99
null 98
Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor 98
Nociceptin/orphanin FQ receptor ligands, 98
Nociceptin/orphanin FQ inhibits electrically induced contractions of the human bronchus via NOP receptor activation 97
Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH2: Identification of highly potent agonists of the nociceptin/orphanin FQ receptor 97
Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors 96
Angiotensin II-induced increase of T-type Ca2+ current and decrease of L-type Ca2+ current in heart cells 96
Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Galpha(qi5). 94
Contractile activity of endothelins and their precursors in human umbilical artery and vein: identification of distinct endothelin-converting enzyme activities 94
Pharmacology of [tyr1]nociceptin analogs: receptor binding and bioassay studies 92
Anxiolytic and antidepressant-like activities of UFP-512, a novel selective delta opiold receptor agonist 92
null 92
FR 173657: a new, potent, nonpeptide kinin B2 receptor antagonist. An in vitro study 92
Pharmacology of nociceptin and its receptor: a novel therapeutic target 91
Further studies on nociceptin/orphanin FQ related peptides: discovery of a new chemical template with antagonist activity on the OP4 receptor. 89
null 88
Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test 88
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen(5), DTrp(7), Dab(8)] urotensin II(4-11) (UFP-803) 88
In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist 87
Characterization of the human vascular kinin B2 receptor by binding assays. 86
null 84
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 83
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 82
Effects of Ro 64-6198 it nociceptin/orphanin FQ-sensitive isolated tissues 82
Structure-activity studies on neuropeptide S - Identification of the amino acid residues crucial for receptor activation 81
Highly potent full and partial agonists and anatagonists of the nociceptin/orphanin FQ receptor 80
null 79
ANALOGHI DERMASEPTINICI AD ATTIVITA’ ANTIMICROBICA 79
Expression and biological activity of B1 bradykinin receptors in two experimental models of epilepsy 78
Receptor binding profile of novel nociceptin/orphanin FQ receptor ligands in mouse brain membranes. 77
In vitro characterization of FR 190997, the first non peptide B2 receptor agonist receptor binding and bioassay in the human umbilical vein 77
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]NPS. 74
Pharmacological characterisation of [(pX)Phe(4)]nociceptin(1-13)amide analogues - 1. In vitro studies 73
Identificazione di un antagonista del recettore UT 70
MEN 11270, a novel selective constrained peptide antagonist with high affinity at the human B-2 kinin receptor 70
Totale 10.866
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.662
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.662
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.527 0 0 0 0 0 312 224 287 219 262 145 78
2020/20211.495 142 158 60 214 68 159 53 177 30 166 204 64
2021/20221.308 44 137 96 98 87 56 73 72 57 94 123 371
2022/20231.347 126 52 62 173 225 177 113 100 199 7 68 45
2023/2024641 77 78 38 16 41 137 21 42 13 13 14 151
2024/2025775 55 51 208 109 340 12 0 0 0 0 0 0
Totale 11.837